Inactive Instrument

News Mallinckrodt plc

Equities

MNK

IE000O3L0NQ3

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Mallinckrodt plc Reports Earnings Results for the Full Year Ended December 29, 2023	27/03	CI
Mallinckrodt plc Reports Earnings Results for the Fourth Quarter Ended December 29, 2023	27/03	CI
Mallinckrodt plc Provides Earnings Guidance for the Year 2024	27/03	CI
Mallinckrodt Appoints Paul O'neill as Executive Vice President, Quality & Operations, Specialty Brands	04/03	CI
Mallinckrodt Announces Journal Publication of Economic Evidence for TERLIVAZ for Injection in Adults with Hepatorenal Syndrome	22/12	AQ
Mallinckrodt Announces FDA Clearance of the INOmax EVOLVE DS Delivery System and Approval of the INOmax Mini-Cylinder	08/12	AQ
Mallinckrodt plc Announces FDA Clearance of the INOmax® EVOLVE? DS Delivery System and Approval of the INOmax® Mini-Cylinder	08/12	CI
Mallinckrodt plc Announces Resignation of Sigurdur Olafsson as Chief Executive Officer	15/11	CI
Mallinckrodt plc Announces Board Changes	15/11	CI
Drugmaker Mallinckrodt emerges from bankruptcy	15/11	RE
Drugmaker Mallinckrodt emerges from bankruptcy	15/11	RE
Mallinckrodt plc Emerged from Bankruptcy	14/11	CI
Mallinckrodt to Present Breadth of Data on TERLIVAZ for Injection in Adult Patients with Hepatorenal Syndrome at the American Association for the Study of Liver Diseases 2023 Liver Meeting	09/11	AQ
Mallinckrodt plc to Present Breadth of Data on Terlivaz (Terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome At the American Association for the Study of Liver Diseases 2023 Liver Meeting	08/11	CI
Mallinckrodt: Q3 Earnings Snapshot	07/11	AQ
Mallinckrodt plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 29, 2023	07/11	CI
Mallinckrodt plc Revises Earnings Guidance for the Full-Year of 2023	07/11	CI
Mallinckrodt to Present Data on TERLIVAZ for Injection in Adult Patients with Hepatorenal Syndrome at the American Society of Nephrology Kidney Week 2023 Scientific Meeting	02/11	AQ
Mallinckrodt Presents Latest Health Economics Data on Acthar Gel (Repository Corticotropin Injection) At the Academy of Managed Care Pharmacy Nexus 2023	26/23/26	CI
Mallinckrodt to Present Data on TERLIVAZ for Injection in Adult Patients with Hepatorenal Syndrome at the American College of Gastroenterology Annual Scientific Meeting	23/23/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Mallinckrodt plc

Equities

MNK

IE000O3L0NQ3

Summary

Filters